Comment – Active Surveillance vs. Adjuvant Therapy in Clinical Stage I Non-seminomatous Germ Cell Testicular Cancer


Klin Onkol 2016; 29(2): 111-112.

Over the last 35 years, the distribution of stage in initial dia gnosis of non-seminomatous germ cell testicular tumors (NSGCTT) has changed with more patients being dia gnosed at earlier stages. Approximately 30– 50% of patients with NSGCTT present with clinical stage I (CSI) of disease. 

Plný text v PDF